Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Outcome heterogeneity and bias in acute experimental spinal cord injury: A meta-analysis.

Watzlawick R, Antonic A, Sena ES, Kopp MA, Rind J, Dirnagl U, Macleod M, Howells DW, Schwab JM.

Neurology. 2019 Jul 2;93(1):e40-e51. doi: 10.1212/WNL.0000000000007718. Epub 2019 Jun 7.

2.

The Incidence and Management of Moderate to Severe Head Injury.

Maegele M, Lefering R, Sakowitz O, Kopp MA, Schwab JM, Steudel WI, Unterberg A, Hoffmann R, Uhl E, Marzi I.

Dtsch Arztebl Int. 2019 Mar 8;116(10):167-173. doi: 10.3238/arztebl.2019.0167.

3.

Release of astroglial vimentin by extracellular vesicles: Modulation of binding and internalization of C3 transferase in astrocytes and neurons.

Adolf A, Rohrbeck A, Münster-Wandowski A, Johansson M, Kuhn HG, Kopp MA, Brommer B, Schwab JM, Just I, Ahnert-Hilger G, Höltje M.

Glia. 2019 Apr;67(4):703-717. doi: 10.1002/glia.23566. Epub 2018 Nov 28.

PMID:
30485542
4.

Corroborating evidence by exploring sources of bias in observational spinal cord injury studies.

Kopp MA, Martus P, Watzlawick R, DeVivo MJ, Chen Y, Schwab JM.

Neurology. 2018 Sep 4;91(10):476-479. doi: 10.1212/WNL.0000000000006123. Epub 2018 Aug 3. No abstract available.

5.

Markedly Deranged Injury Site Metabolism and Impaired Functional Recovery in Acute Spinal Cord Injury Patients With Fever.

Gallagher MJ, Zoumprouli A, Phang I, Schwab JM, Kopp MA, Liebscher T, Papadopoulos MC, Saadoun S.

Crit Care Med. 2018 Jul;46(7):1150-1157. doi: 10.1097/CCM.0000000000003134.

PMID:
29629987
6.

Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury.

Francos-Quijorna I, Santos-Nogueira E, Gronert K, Sullivan AB, Kopp MA, Brommer B, David S, Schwab JM, López-Vales R.

J Neurosci. 2017 Nov 29;37(48):11731-11743. doi: 10.1523/JNEUROSCI.1395-17.2017. Epub 2017 Nov 6.

7.

Acute transient spinal paralysis and cardiac symptoms following an accidental epidural potassium infusion - a case report.

Kreutzträger M, Kopp MA, Liebscher T.

BMC Anesthesiol. 2017 Oct 6;17(1):135. doi: 10.1186/s12871-017-0425-0.

8.

Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflex.

Prüss H, Tedeschi A, Thiriot A, Lynch L, Loughhead SM, Stutte S, Mazo IB, Kopp MA, Brommer B, Blex C, Geurtz LC, Liebscher T, Niedeggen A, Dirnagl U, Bradke F, Volz MS, DeVivo MJ, Chen Y, von Andrian UH, Schwab JM.

Nat Neurosci. 2017 Nov;20(11):1549-1559. doi: 10.1038/nn.4643. Epub 2017 Sep 18.

PMID:
28920935
9.

Long-term functional outcome in patients with acquired infections after acute spinal cord injury.

Kopp MA, Watzlawick R, Martus P, Failli V, Finkenstaedt FW, Chen Y, DeVivo MJ, Dirnagl U, Schwab JM.

Neurology. 2017 Feb 28;88(9):892-900. doi: 10.1212/WNL.0000000000003652. Epub 2017 Jan 27.

10.

Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study.

Laginha I, Kopp MA, Druschel C, Schaser KD, Brommer B, Hellmann RC, Watzlawick R, Ossami-Saidi RR, Prüss H, Failli V, Meisel C, Liebscher T, Prilipp E, Niedeggen A, Ekkernkamp A, Grittner U, Piper SK, Dirnagl U, Killig M, Romagnani C, Schwab JM.

BMC Neurol. 2016 Sep 13;16:170. doi: 10.1186/s12883-016-0681-5.

11.

SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol.

Kopp MA, Liebscher T, Watzlawick R, Martus P, Laufer S, Blex C, Schindler R, Jungehulsing GJ, Knüppel S, Kreutzträger M, Ekkernkamp A, Dirnagl U, Strittmatter SM, Niedeggen A, Schwab JM.

BMJ Open. 2016 Jul 26;6(7):e010651. doi: 10.1136/bmjopen-2015-010651.

12.

Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis.

Watzlawick R, Rind J, Sena ES, Brommer B, Zhang T, Kopp MA, Dirnagl U, Macleod MR, Howells DW, Schwab JM.

PLoS Biol. 2016 May 31;14(5):e1002468. doi: 10.1371/journal.pbio.1002468. eCollection 2016 May.

13.

Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level.

Brommer B, Engel O, Kopp MA, Watzlawick R, Müller S, Prüss H, Chen Y, DeVivo MJ, Finkenstaedt FW, Dirnagl U, Liebscher T, Meisel A, Schwab JM.

Brain. 2016 Mar;139(Pt 3):692-707. doi: 10.1093/brain/awv375. Epub 2016 Jan 10.

14.

Scribes: letting doctors do what they do best.

Kopp MA, Marks BM.

R I Med J (2013). 2015 Jun 1;98(6):33-4. No abstract available.

PMID:
26020261
15.

The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury.

Schwab JM, Zhang Y, Kopp MA, Brommer B, Popovich PG.

Exp Neurol. 2014 Aug;258:121-129. doi: 10.1016/j.expneurol.2014.04.023. Review.

16.

Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis.

Watzlawick R, Sena ES, Dirnagl U, Brommer B, Kopp MA, Macleod MR, Howells DW, Schwab JM.

JAMA Neurol. 2014 Jan;71(1):91-9. doi: 10.1001/jamaneurol.2013.4684. Review.

PMID:
24297045
17.

The SCIentinel study--prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)--study protocol and interim feasibility data.

Kopp MA, Druschel C, Meisel C, Liebscher T, Prilipp E, Watzlawick R, Cinelli P, Niedeggen A, Schaser KD, Wanner GA, Curt A, Lindemann G, Nugaeva N, Fehlings MG, Vajkoczy P, Cabraja M, Dengler J, Ertel W, Ekkernkamp A, Martus P, Volk HD, Unterwalder N, Kölsch U, Brommer B, Hellmann RC, Saidy RR, Laginha I, Prüss H, Failli V, Dirnagl U, Schwab JM.

BMC Neurol. 2013 Nov 9;13:168. doi: 10.1186/1471-2377-13-168.

18.

Functional neurological recovery after spinal cord injury is impaired in patients with infections.

Failli V, Kopp MA, Gericke C, Martus P, Klingbeil S, Brommer B, Laginha I, Chen Y, DeVivo MJ, Dirnagl U, Schwab JM.

Brain. 2012 Nov;135(Pt 11):3238-50. doi: 10.1093/brain/aws267. Epub 2012 Oct 25.

PMID:
23100450
19.

Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury.

Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, Strittmatter SM, Dirnagl U, Schwab JM.

Cell Tissue Res. 2012 Jul;349(1):119-32. doi: 10.1007/s00441-012-1334-7. Epub 2012 Feb 21. Review.

20.

Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau.

Prüss H, Kopp MA, Brommer B, Gatzemeier N, Laginha I, Dirnagl U, Schwab JM.

Brain Pathol. 2011 Nov;21(6):652-60. doi: 10.1111/j.1750-3639.2011.00488.x. Epub 2011 Apr 24.

PMID:
21418368
21.

Spinal cord injury induces differential expression of the profibrotic semaphorin 7A in the developing and mature glial scar.

Kopp MA, Brommer B, Gatzemeier N, Schwab JM, Prüss H.

Glia. 2010 Nov 1;58(14):1748-56. doi: 10.1002/glia.21045.

PMID:
20645410
22.

Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients.

Baid-Agrawal S, Frei U, Reinke P, Schindler R, Kopp MA, Martus P, Berg T, Juergensen JS, Anker SD, Doehner W.

Am J Transplant. 2009 Dec;9(12):2777-84. doi: 10.1111/j.1600-6143.2009.02843.x. Epub 2009 Oct 21.

Supplemental Content

Support Center